• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    UL Solutions Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    2/19/26 6:56:37 AM ET
    $ULS
    Precision Instruments
    Health Care
    Get the next $ULS alert in real time by email
    uls-20260219
    false000190144000019014402026-02-192026-02-19






    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    ___________________________________
    FORM 8-K
    ___________________________________
    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934
    Date of Report (date of earliest event reported): February 19, 2026
    ___________________________________
    UL Solutions Inc.
    (Exact name of registrant as specified in its charter)
    ___________________________________

    Delaware
    (State or other jurisdiction of
    incorporation or organization)
    001-42012
    (Commission File Number)
    27-0913800
    (I.R.S. Employer Identification Number)
    333 Pfingsten Road
    Northbrook, Illinois 60062
    (Address of principal executive offices and zip code)
    (847) 272-8800
    (Registrant's telephone number, including area code)
    ___________________________________
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class
    Trading Symbol
    Name of each exchange on which registered
    Class A Common Stock, par value $0.001 per shareULSNew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company    ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐








    Item 2.02. Results of Operations and Financial Condition
    On February 19, 2026, UL Solutions Inc. (the “Company”) issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2025. The full text of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
    The information contained or incorporated by reference in this Item 2.02, including the press release furnished herewith as Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such a filing.
    Item 9.01. Financial Statements and Exhibits
    (d) Exhibits
    Exhibit NumberDescription
    99.1
    Press Release of UL Solutions Inc., dated as of February 19, 2026
    104Cover page interactive data file (embedded with the inline XBRL document)
    Signature
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
    UL Solutions Inc.
    Date: February 19, 2026
    By:
    /s/ Ryan D. Robinson
    Ryan D. Robinson
    Executive Vice President and Chief Financial Officer


    Get the next $ULS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ULS

    DatePrice TargetRatingAnalyst
    2/17/2026$86.00Buy
    BofA Securities
    12/17/2025$97.00Neutral → Outperform
    Robert W. Baird
    11/5/2025$84.00Overweight → Neutral
    Analyst
    5/14/2025$71.00Buy → Neutral
    Citigroup
    10/7/2024$60.00Buy
    Citigroup
    7/12/2024$41.00 → $46.00Outperform → Neutral
    Robert W. Baird
    More analyst ratings

    $ULS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Shannon James M

    4 - UL Solutions Inc. (0001901440) (Issuer)

    1/7/26 7:10:05 PM ET
    $ULS
    Precision Instruments
    Health Care

    Executive VP & CFO Robinson Ryan D gifted 135,956 shares and received a gift of 135,956 shares, decreasing direct ownership by 99% to 1,000 units (SEC Form 4)

    4 - UL Solutions Inc. (0001901440) (Issuer)

    1/7/26 7:10:07 PM ET
    $ULS
    Precision Instruments
    Health Care

    EVP & CCO Uggetti Alberto converted options into 1,007 shares and covered exercise/tax liability with 247 shares, increasing direct ownership by 8% to 10,045 units (SEC Form 4)

    4 - UL Solutions Inc. (0001901440) (Issuer)

    1/5/26 5:40:09 PM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities resumed coverage on UL Solutions Inc. with a new price target

    BofA Securities resumed coverage of UL Solutions Inc. with a rating of Buy and set a new price target of $86.00

    2/17/26 7:29:05 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Inc. upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded UL Solutions Inc. from Neutral to Outperform and set a new price target of $97.00

    12/17/25 8:48:07 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Inc. downgraded by Analyst with a new price target

    Analyst downgraded UL Solutions Inc. from Overweight to Neutral and set a new price target of $84.00

    11/5/25 7:29:40 AM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    UL Solutions Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results, Announces 2026 Growth Outlook and Increases Quarterly Dividend

    Fourth Quarter 20251 Strong revenue growth of 6.8% to $789 million, including 5.7% organic growth Net income of $71 million, including a $37 million pre-tax restructuring charge, decreased 16.5%, Adjusted Net Income of $114 million increased 11.8% Diluted earnings per share of $0.32 decreased 20.0%, Adjusted Diluted Earnings Per Share of $0.53 increased 8.2% Adjusted EBITDA of $217 million increased 28.4%, Adjusted EBITDA margin of 27.5% expanded 460 basis points Full-Year 20252 Strong revenue growth of 6.4% to $3,053 million, including 6.2% organic growth Net income of $345 million, including a $35 million pre-tax restructuring charge, unchanged from prior period, Adju

    2/19/26 7:00:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Sets Date for Fourth Quarter and Full Year 2025 Results

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it will release financial results for the fourth quarter and full year 2025 before the market opens on Thursday, Feb. 19. Management will host a webcast and conference call that same day at 8:30 a.m. EST (7:30 a.m. CST) to review results. Webcast and Conference Call The conference call will be broadcast live over the Internet. Additionally, a slide presentation will accompany the conference call. To listen to the call and view the slides, please visit the Investors section of UL Solutions' website at www.ul.com. For those who are unable to listen to the live broadcast, an audio replay of the confere

    2/5/26 7:00:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Debuts Testing and Certification Framework for Safer Plug-In Solar Across the United States

    UL Solutions has launched a dedicated testing and certification program for plug-in solar systems, also known as balcony solar, creating a clear safety framework to support their installation and use across the United States. The program establishes construction, performance and labeling criteria that help manufacturers design plug-in solar products meeting safety standards. By addressing safety risks associated with plug-in solar systems, UL Solutions is helping to enable safer, more accessible solar power options for residents of multi-unit buildings and supporting emerging state-level legislation. UL Solutions (NYSE:ULS), a global leader in applied safety science, today announc

    1/8/26 4:15:00 PM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    SEC Filings

    View All

    SEC Form 10-K filed by UL Solutions Inc.

    10-K - UL Solutions Inc. (0001901440) (Filer)

    2/19/26 4:23:42 PM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - UL Solutions Inc. (0001901440) (Filer)

    2/19/26 6:56:37 AM ET
    $ULS
    Precision Instruments
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by UL Solutions Inc.

    SCHEDULE 13G/A - UL Solutions Inc. (0001901440) (Subject)

    2/13/26 4:30:00 PM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Leadership Updates

    Live Leadership Updates

    View All

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    UL Solutions Breaks Ground on Global Fire Science Center of Excellence in Illinois

    The advanced fire safety testing and R&D facility will be dedicated to identifying, evaluating and mitigating fire risks. UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced the beginning of construction on its state-of-the-art Global Fire Science Center of Excellence, one of the company's largest laboratory investments to date, helping to reduce fire risks globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250826231103/en/UL Solutions has announced the beginning of construction on its state-of-the-art Global Fire Science Center of Excellence, one of the company's largest laboratory i

    8/26/25 5:30:00 PM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Inc. Names New Chief Legal Officer

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it appointed Scott D'Angelo as executive vice president and chief legal officer, effective April 21, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250311928632/en/UL Solutions names Scott D'Angelo as executive vice president and chief legal officer (Photo: Business Wire) D'Angelo's appointment fills a vacant role and he joins the company's executive leadership team, reporting to President and CEO Jennifer Scanlon. D'Angelo will oversee the legal, brand integrity, ethics and compliance functions. He most recently served as vice presiden

    3/11/25 9:15:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Financials

    Live finance-specific insights

    View All

    UL Solutions Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results, Announces 2026 Growth Outlook and Increases Quarterly Dividend

    Fourth Quarter 20251 Strong revenue growth of 6.8% to $789 million, including 5.7% organic growth Net income of $71 million, including a $37 million pre-tax restructuring charge, decreased 16.5%, Adjusted Net Income of $114 million increased 11.8% Diluted earnings per share of $0.32 decreased 20.0%, Adjusted Diluted Earnings Per Share of $0.53 increased 8.2% Adjusted EBITDA of $217 million increased 28.4%, Adjusted EBITDA margin of 27.5% expanded 460 basis points Full-Year 20252 Strong revenue growth of 6.4% to $3,053 million, including 6.2% organic growth Net income of $345 million, including a $35 million pre-tax restructuring charge, unchanged from prior period, Adju

    2/19/26 7:00:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Sets Date for Fourth Quarter and Full Year 2025 Results

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it will release financial results for the fourth quarter and full year 2025 before the market opens on Thursday, Feb. 19. Management will host a webcast and conference call that same day at 8:30 a.m. EST (7:30 a.m. CST) to review results. Webcast and Conference Call The conference call will be broadcast live over the Internet. Additionally, a slide presentation will accompany the conference call. To listen to the call and view the slides, please visit the Investors section of UL Solutions' website at www.ul.com. For those who are unable to listen to the live broadcast, an audio replay of the confere

    2/5/26 7:00:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Announces Quarterly Dividend

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced that its board of directors has declared a quarterly dividend of $0.13 per share. The dividend will be paid on Dec. 8 to shareholders of record as of the close of business on Nov. 28. About UL Solutions A global leader in applied safety science, UL Solutions (NYSE:ULS) transforms safety, security and sustainability challenges into opportunities for customers in more than 110 countries. UL Solutions delivers testing, inspection and certification services, together with software products and advisory offerings, that support our customers' product innovation and business growth. The UL Mark serves as

    11/11/25 4:45:00 PM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by UL Solutions Inc.

    SC 13G/A - UL Solutions Inc. (0001901440) (Subject)

    11/13/24 12:26:41 PM ET
    $ULS
    Precision Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by UL Solutions Inc.

    SC 13G/A - UL Solutions Inc. (0001901440) (Subject)

    11/12/24 5:49:12 PM ET
    $ULS
    Precision Instruments
    Health Care

    SEC Form SC 13G filed by UL Solutions Inc.

    SC 13G - UL Solutions Inc. (0001901440) (Subject)

    11/12/24 10:34:15 AM ET
    $ULS
    Precision Instruments
    Health Care